NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india) arrow 11706.80 15.30 0.13%
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

ImmunoCellular Therapeutics, Ltd. (AMEX: IMUC)

 
IMUC Technical Analysis
2
As on 31st Oct 2017 IMUC Share Price closed @ 0.38 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.54 & Buy for SHORT-TERM with Stoploss of 0.35 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

IMUC Share Price

Open 0.38 Change Price %
High 0.38 1 Day 0.00 0.00
Low 0.36 1 Week 0.00 0.00
Close 0.38 1 Month 0.00 0.00
Volume 1423841 1 Year 0.30 375.00
52 Week High 4.27 | 52 Week Low 0.06
 
AMEX USA Most Active Stocks
PAL 0.05 -50.00%
NGD 3.29 -6.80%
RBY 0.03 -70.00%
LODE 0.12 -7.69%
PBTH 8.23 0.37%
GGR 0.02 100.00%
VTG 0.05 -16.67%
SYRG 8.13 0.87%
GSX 0.02 0.00%
SHZ 0.10 -16.67%
 
AMEX USA Top Gainers Stocks
GGR 0.02 100.00%
ATC 0.37 60.87%
ATC 0.37 60.87%
ATC 0.37 60.87%
ATC 0.37 60.87%
MBA 0.20 25.00%
MBA 0.20 25.00%
MBA 0.20 25.00%
IG 7.68 22.49%
IG 7.68 22.49%
 
AMEX USA Top Losers Stocks
RBY 0.03 -70.00%
PAL 0.05 -50.00%
PAL 0.05 -50.00%
PAL 0.05 -50.00%
QBC 0.20 -33.33%
LBY 6.84 -25.33%
ATL 0.06 -25.00%
ATL 0.06 -25.00%
SNT 0.12 -20.00%
INV 0.14 -17.65%
 
 
IMUC
Daily Charts
IMUC
Intraday Charts
Whats New @
Bazaartrend
IMUC
Free Analysis
 
IMUC Important Levels Intraday
SUPPORT0.00
SUPPORT0.00
RESISTANCE0.40
RESISTANCE0.39
SUPPORT0.37
SUPPORT0.36
SUPPORT0.00
SUPPORT0.00
 
IMUC Target for Month June
4th UP TARGET0.67
3rd UP TARGET0.58
2nd UP TARGET0.52
1st UP TARGET0.46
1st DOWN TARGET0.3
2nd DOWN TARGET0.24
3rd DOWN TARGET0.18
4th DOWN TARGET0.09
 
IMUC Weekly Target
4th UP TARGET0.00
3rd UP TARGET0.00
2nd UP TARGET0.00
1st UP TARGET0.00
1st DOWN TARGET0.00
2nd DOWN TARGET0.00
3rd DOWN TARGET0.00
4th DOWN TARGET0.00
 
IMUC Target for Year 2019
4th UP TARGET0
3rd UP TARGET0
2nd UP TARGET0
1st UP TARGET0
1st DOWN TARGET0
2nd DOWN TARGET0
3rd DOWN TARGET0
4th DOWN TARGET0
 
 
IMUC Other Details
Segment EQ
Market Capital 79347032.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.imuc.com
 
IMUC Address
IMUC
23622 Calabasas Road
Suite 300
Calabasas, CA 91302
United States
Phone: 818-264-2300
Fax: 818-224-5287
 
IMUC Latest News
 
Your Comments and Response on ImmunoCellular Therapeutics, Ltd.
 
IMUC Business Profile
ImmunoCellular Therapeutics, Ltd., a clinical-stage biotechnology company, develops immune-based therapies for the treatment of brain and ovarian cancers. Its lead product candidate includes ICT-107, a dendritic cell (DC) vaccine that completed completed Phase II testing trials for the treatment of glioblastoma multiforme (GBM). The company also develops other therapeutic DC vaccines, such as ICT-121 to treat recurrent GBM and other solid tumor cancers, as well as ovarian, pancreatic, and breast cancers; and ICT-140 that targets 7 tumor-associated antigens expressed on ovarian cancer cells. In addition, it has a differential immunization for antigen and antibody discovery platform for discovering monoclonal antibodies for therapeutic and diagnostic development. The company was formerly known as Optical Molecular Imaging, Inc. and changed its name to ImmunoCellular Therapeutics, Ltd. in November 2006. ImmunoCellular Therapeutics, Ltd. is based in Calabasas, California.
 
2005-2019 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service